4/A
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-028687
Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-04-20 | Option exercise | +5,000 | $6.32 | $31,600 | 6,000 | D |
| Cohen Chad M Chief Financial Officer | 2020-04-20 | Option exercise | +5,000 | $4.07 | $20,350 | 11,000 | D |
| Cohen Chad M Chief Financial Officer | 2020-04-20 | Sale | −10,000 | $30.00 | $300,000 | 1,000 | D |
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2020-04-20 | Option exercise · Stock Option (Right to Buy) | −5,000 | 30,000 | D | ||
| Cohen Chad M Chief Financial Officer | 2020-04-20 | Option exercise · Stock Option (Right to Buy) | −5,000 | 740,000 | D | ||
| Open-market sales · 10,000 sh · avg $30.00 · $300,000 | |||||||
Loading xslF345X03/doc4a.xml…